Hyperion DeFi, Inc. Insider Trading

HYPD

⊜ Compare

Last 12 months

Insiders bought 641K on the open market and sold nothing.

Net open-market

+641K

6 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

5 / 0

executives and directors

Last open-market buy

Jun 2026

Jun 2, 2026

Get an email when HYPD's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jun 1 – 2	Hyunsu Jung See Remarks	Bought 4 parts	8,000	$3.70 average	30K	0.6%	Form 4
Dec 31, 2025	David R. Knox Chief Financial Officer	Bought	27,950	$3.59	100K	9.3%	Form 4
Dec 26, 2025 – Dec 29, 2025	Ellen R Strahlman Director	Bought 4 parts	30,880	$3.66 average	113K	32%	Form 4
Dec 18, 2025	Ellen R Strahlman Director	Bought 2 parts	38,444	$3.14 average	121K	29%	Form 4
Dec 17, 2025	Happy David Walters Director	Bought	61,930	$3.02	187K	124%	Form 4
Dec 17, 2025	Michael S Geltzeiler Director	Bought	30,000	$3.01	90K	52%	Form 4

Jun 1 – 2
Hyunsu Jung
See Remarks · bought 8,000 at avg $3.70
30K
0.6% of stake
Dec 31, 2025
David R. Knox
Chief Financial Officer · bought 27,950 at $3.59
100K
9.3% of stake
Dec 26, 2025 – Dec 29, 2025
Ellen R Strahlman
Director · bought 30,880 at avg $3.66
113K
32% of stake
Dec 18, 2025
Ellen R Strahlman
Director · bought 38,444 at avg $3.14
121K
29% of stake
Dec 17, 2025
Happy David Walters
Director · bought 61,930 at $3.02
187K
124% of stake
Dec 17, 2025
Michael S Geltzeiler
Director · bought 30,000 at $3.01
90K
52% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch HYPD, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with HYPD

CompareIntrinsic value

ATXIAvenue Therapeutics Inc.

$0.40+0.00%10

BSPKBespoke Extracts Inc.

$0.00+0.00%30

DAREDare Bioscience Inc.

$0.66+1.83%10

NWBONorthwest Biotherapeutics Inc.

$0.17-2.94%26

VTGNVistaGen Therapeutics Inc.

$0.18+5.88%10

LPCNLipocine Inc.

$1.44-1.37%40

LGVNLongeveron Inc.

$1.78+0.00%10

PMHSPolomar Health Services Inc.

$0.19+0.00%40

Spot a number that looks wrong? Check it in HYPD's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing HYPD

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.